ARID1A and gastric cancer: Our study showed that poor prognostic significance of ARID1A in GC existed in EBV (+) > 5% subgroup, which was not concordant with the findings that ARID1A expression loss could predict poor OS in Asians and proportion of proximal disease ≤30% subgroup.